TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Allskog Bio AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,106
|
1,861
|
2,162 |
Financial expenses |
32
|
34
|
35 |
Earnings before taxes |
201
|
209
|
253 |
Total assets |
1,854
|
2,128
|
1,902 |
Current assets |
619
|
823
|
759 |
Current liabilities |
405
|
538
|
268 |
Equity capital |
1,021
|
987
|
887 |
- share capital |
89
|
95
|
100 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
55.1%
|
46.4%
|
46.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
9.5%
|
11.2%
|
11.7% |
Return on assets (ROA) |
12.6%
|
11.4%
|
15.1% |
Current ratio |
152.8%
|
153.0%
|
283.2% |
Return on equity (ROE) |
19.7%
|
21.2%
|
28.5% |
Change turnover |
363
|
-187
|
-406 |
Change turnover % |
21%
|
-9%
|
-16% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.